Can-Fite BioPharma Ltd. CANF
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 7.09% | 0.00% | -1.56% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -95.65% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -32.00% | 0.00% | -68.94% | 0.00% |
| Change in Net Operating Assets | 0.00% | -219.57% | 0.00% | 395.93% | 0.00% |
| Cash from Operations | 0.00% | -26.61% | 0.00% | 11.68% | 0.00% |
| Capital Expenditure | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 66.67% | 0.00% | -200.00% | 0.00% |
| Cash from Investing | 0.00% | 66.64% | 0.00% | -200.07% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | -39.85% | 0.00% | 85.92% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -39.85% | 0.00% | 85.92% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | 0.00% | -88.89% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -174.62% | 0.00% | -156.84% | 0.00% |